Product
Timolol Maleate Ophthalmic Solution
Aliases
Timolol Maleate Ophthalmic Solution, 0.5%
Name
Timolol Maleate
INN Name
Timolol Maleate
FDA Approved
Yes
3 clinical trials
7 organizations
3 indications
2 documents
Indication
CataractIndication
GlaucomaIndication
ocular hypertensionClinical trial
A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety, Efficacy, and Dose-response of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants to Timolol Maleate Ophthalmic Solution, USP 0.5%Status: Completed, Estimated PCD: 2017-08-01
Clinical trial
A Phase III, Randomized, Double-Masked, Active-Controlled, Parallel-Group, Multi-center Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 StudyStatus: Completed, Estimated PCD: 2019-12-06
Document
DailyMed Label: Timolol MaleateOrganization
BAUSCH & LOMB INCORPORATEDOrganization
Mylan Pharmaceuticals Inc.Organization
Athem LLCDocument
DailyMed Label: Timoptic-XEOrganization
Bausch & Lomb Americas Inc.Organization
MICRO LABS LIMITEDOrganization
Akorn - Strides LLC Organization
Oceanside Pharmaceuticals